ArticleCVIR endovascular2025

Prospective analysis of bleomycin electrosclerotherapy for clinical outcome and volume reduction in therapy refractory slow-flow malformations.

Anna Deleu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.